Drugmaker Novartis to acquire biotech firm Avidity Biosciences for $12 billion in cash Mergers & Acquisitions October 27, 2025 The Swiss drugmaker on Sunday said it agreed to acquire U.S. biotech firm Avidity Biosciences for about $12 billion in cash